OAKVILLE, ON, March 15, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q4 2018 financial results conference call on Tuesday, March 19, 2019. The call will be hosted by Robert Tessarolo, President and Chief Executive Officer, and Stephen Lemieux, Chief Financial Officer. The Company will issue its financial results on the morning of March 19, 2019.
CONFERENCE CALL DETAILS
Tuesday, March 19, 2019
8:30 a.m. EDT
DIAL IN NUMBER:
(416) 764-8609 or (888) 390-0605
(888) 390-0541 (playback code 671895)
Available until midnight (EDT) March 26, 2019
The audio webcast can be accessed at http://cipher.investorroom.com/ under Investor Relations or at
About Cipher Pharmaceuticals Inc.
Cipher (TSX:CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. Cipher is focused on a three-pronged growth strategy – including acquisitions, in-licensing, and selective investments in drug development – to assemble a broad portfolio of prescription products that serve unmet medical needs. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.